| Financial Year |
March 31 2023 |
| Monetary Funds |
1,183,463,333.36 |
| Held-for-trading Financial Assets |
58,097,812.10 |
| Notes Receivable |
674,676,285.61 |
| Accounts Receivable |
1,462,279,112.05 |
| Advances to Suppliers |
56,792,902.59 |
| Other Receivables |
38,082,503.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
807,266,724.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,673,785.05 |
| Total Current Assets |
4,443,545,297.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,087,069.09 |
| Investment Properties |
-- |
| Fixed Assetes |
484,473,471.07 |
| Under-construction Projects |
88,726,012.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,540,812.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,962,833.61 |
| Deferred Income Tax Assets |
43,765,599.82 |
| Other Non-Current Assets |
59,408,987.45 |
| Sub-Total of Non-Current Assets |
921,740,905.49 |
| Total Assets |
5,365,286,202.69 |
| Short-Term Loans |
586,898,246.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
358,779,457.50 |
| Accounts Payable |
154,522,709.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,846,447.14 |
| Taxes Payable |
24,168,114.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,342,237.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,715,188.57 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,208,744,883.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,562,201.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,123,236.96 |
| Total Liabilities |
1,246,868,120.73 |
| Paid-In Capital(Or Share Stock) |
232,400,000.00 |
| Capital Surplus |
1,349,089,621.27 |
| Surplus Reserve |
116,202,000.00 |
| LESS:Treasury Stock |
125,546,269.50 |
| Undistributed Profits |
2,536,885,260.49 |
| Minority Stockholder's Interest |
10,322,352.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,108,095,729.89 |
| Owner's Equity（Stockholder's Equity） |
4,118,418,081.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,365,286,202.69 |
